Trial Testing New GLP-1 Drug To Reduce Pain of Peripheral Neuropathy Preliminary evidence suggests that GLP-1 drugs may help people with diabetes-related peripheral neuropathy
Non-diabetic populations : Most data so far are in people with T2DM or obesity
Including adequate protein at mealsfrom sources such as fish, poultry, eggs, Greek yoghurt, and plant-based options like tofucan enhance postprandial (after-meal) GLP-1 response
GLP-1 medications are prescription drugs with documented side effects and contraindications
BCBS Massachusetts, BCBS Michigan, BCBS Vermont, Independence Blue Cross in Pennsylvania, Blue Cross of Idaho, and Highmark (which operates across Pennsylvania, West Virginia, New York, and Delaware) all implemented restrictions